Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Balfour Beatty H1 profit underpinned by UK construction arm

(Sharecast News) - Infrastructure group Balfour Beatty backed its full-year expectations on Wednesday as it posted a jump in first-half profit, underpinned by its UK construction business. In the half year ended 27 June, pre-tax profit rose to £132m from £112m in the same period a year ago, on revenue of £5.2bn, up from £4.7bn.

Balfour said the UK construction arm delivered profitable underlying growth to achieve its 3% margin target one year ahead of expectations. The division achieved a 3.6% PFO (profit from operations) margin.

The US construction business posted a first-half loss, however, with a strong Buildings performance offset by cost overruns at one Civils project.

Balfour said the order book grew 6% to £19.5bn, with growth in each segment, and "continues to give clear visibility in the short and medium term".

Chief executive Leo Quinn said: "Our continuing strong cash generation is underpinned by a growing order book with improved margins and lower risk contract forms. This provides the board with increasing confidence in significant future cash generation that supports our ongoing dividends and share buybacks. This is demonstrated by the momentum in our key growth areas in the first half.

"Support Services has delivered a 35% profit uplift driven by the power transmission business, UK Construction has achieved its long-standing 3% margin target earlier than expected and, in US Construction, Buildings reported strong revenue growth from its strategy of focused expansion.

"Furthermore, recent UK Government announcements confirm a deep pipeline of major infrastructure projects which closely align with the group's unique expert capabilities and will further enhance the quality of the future order book."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.